0000822746 false Q1 --12-31 0000822746 2023-01-01 2023-03-31 0000822746 2023-06-08 0000822746 2023-03-31 0000822746 2022-12-31 0000822746 us-gaap:RelatedPartyMember 2023-03-31 0000822746 us-gaap:RelatedPartyMember 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2023-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-12-31 0000822746 2022-01-01 2022-03-31 0000822746 us-gaap:PreferredStockMember 2021-12-31 0000822746 us-gaap:CommonStockMember 2021-12-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822746 us-gaap:RetainedEarningsMember 2021-12-31 0000822746 2021-12-31 0000822746 us-gaap:PreferredStockMember 2022-12-31 0000822746 us-gaap:CommonStockMember 2022-12-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822746 us-gaap:RetainedEarningsMember 2022-12-31 0000822746 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000822746 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000822746 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0000822746 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000822746 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000822746 us-gaap:PreferredStockMember 2022-03-31 0000822746 us-gaap:CommonStockMember 2022-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000822746 us-gaap:RetainedEarningsMember 2022-03-31 0000822746 2022-03-31 0000822746 us-gaap:PreferredStockMember 2023-03-31 0000822746 us-gaap:CommonStockMember 2023-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000822746 us-gaap:RetainedEarningsMember 2023-03-31 0000822746 2021-03-30 2021-04-02 0000822746 2021-04-02 0000822746 2022-01-01 2022-12-31 0000822746 AMNI:OperatingAgreementMember AMNI:GMDOCMember 2022-05-03 0000822746 AMNI:OperatingAgreementMember AMNI:GMDOCMember 2022-05-02 2022-05-03 0000822746 2022-05-15 2022-05-16 0000822746 AMNI:CastelliEnergyLLCMember AMNI:OperatingAgreementMember AMNI:GMDOCMember 2022-05-03 0000822746 AMNI:GMDOCLLCMember AMNI:OperatingAgreementMember 2022-05-03 0000822746 us-gaap:SeriesAPreferredStockMember 2023-03-31 0000822746 AMNI:WestTexasIntermediateMember 2022-12-31 0000822746 2012-12-31 0000822746 AMNI:TexasOilAndGasMember 2012-12-31 0000822746 AMNI:WyomingAndColoradoOilAndGasMember 2012-12-31 0000822746 us-gaap:FairValueInputsLevel1Member 2023-03-31 0000822746 us-gaap:FairValueInputsLevel2Member 2023-03-31 0000822746 us-gaap:FairValueInputsLevel3Member 2023-03-31 0000822746 us-gaap:FairValueInputsLevel1Member 2022-12-31 0000822746 us-gaap:FairValueInputsLevel2Member 2022-12-31 0000822746 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000822746 AMNI:CentralKansasUpliftMember 2023-03-31 0000822746 AMNI:CentralKansasUpliftMember 2022-12-31 0000822746 AMNI:HugotonGasFieldMember 2023-03-31 0000822746 AMNI:HugotonGasFieldMember 2022-12-31 0000822746 AMNI:GMDOCLLCMember 2022-12-31 0000822746 AMNI:GMDOCLLCMember 2023-01-01 2023-03-31 0000822746 AMNI:GMDOCLLCMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2022-09-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2021-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2021-12-31 0000822746 AMNI:DebtSettlementAgreementMember AMNI:ThreePercentageConvertiblePromissoryNotesMember 2021-03-30 2021-03-31 0000822746 AMNI:DebtSettlementAgreementMember AMNI:ThreePercentageConvertiblePromissoryNotesMember 2021-03-31 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-08-29 2021-08-30 0000822746 us-gaap:ConvertibleNotesPayableMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-05-04 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-05-05 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-01-01 2023-03-31 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-08-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-08-29 2021-08-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-08-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:ConvertibleNotesPayableMember 2021-10-28 2021-10-29 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 us-gaap:ConvertibleNotesPayableMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:SubsequentEventMember 2023-05-05 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:SubsequentEventMember 2023-05-04 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-03-31 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2022-12-31 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-29 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-06-08 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-06-07 2022-06-08 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2023-05-05 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2023-05-05 0000822746 us-gaap:ConvertibleNotesPayableMember 2023-03-31 0000822746 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-13 0000822746 AMNI:MayInvestorMember AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:CommonStockMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2022-05-12 2022-05-13 0000822746 2022-06-29 0000822746 AMNI:MayNotesMember 2023-01-09 2023-01-10 0000822746 AMNI:May2022NotesMember 2023-01-10 0000822746 AMNI:May2022NotesMember 2023-01-09 2023-01-10 0000822746 AMNI:May2022NotesMember 2023-03-31 0000822746 AMNI:May2022NotesMember 2022-12-31 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-01-10 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-01-09 2023-01-10 0000822746 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000822746 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-03-31 0000822746 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000822746 us-gaap:RestrictedStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:WarrantMember 2023-01-01 2023-03-31 0000822746 us-gaap:WarrantMember 2022-01-01 2022-03-31 0000822746 AMNI:TwoThowsandAndFifteenPlanMember 2015-09-25 0000822746 AMNI:TwoThowsandAndTwentyOnePlanMember 2021-10-13 0000822746 AMNI:TwoThowsandAndTwentyOnePlanAndTwoThousandAndFifteenMember 2023-03-31 0000822746 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0000822746 us-gaap:StockOptionMember 2022-01-01 2022-03-31 0000822746 us-gaap:RestrictedStockMember AMNI:OfficersDirectorsAndConsultantMember 2022-05-01 2022-05-31 0000822746 us-gaap:RestrictedStockMember AMNI:OfficersDirectorsAndConsultantMember 2020-08-01 2020-08-31 0000822746 2021-01-01 2021-09-30 0000822746 AMNI:ExercisePriceOneMember 2023-03-31 0000822746 AMNI:ExercisePriceOneMember 2023-01-01 2023-03-31 0000822746 AMNI:ExercisePriceTwoMember 2023-03-31 0000822746 AMNI:ExercisePriceTwoMember 2023-01-01 2023-03-31 0000822746 us-gaap:RestrictedStockMember 2021-12-31 0000822746 us-gaap:RestrictedStockMember 2022-03-31 0000822746 us-gaap:RestrictedStockMember 2022-12-31 0000822746 us-gaap:RestrictedStockMember 2023-03-31 0000822746 us-gaap:WarrantMember 2021-12-31 0000822746 us-gaap:WarrantMember 2022-03-31 0000822746 us-gaap:WarrantMember 2022-12-31 0000822746 us-gaap:WarrantMember 2023-03-31 0000822746 us-gaap:WarrantMember 2023-03-31 0000822746 us-gaap:WarrantMember 2023-01-01 2023-03-31 0000822746 us-gaap:WarrantMember 2022-01-01 2022-03-31 0000822746 AMNI:LetterAgreementMember 2021-11-09 0000822746 2021-11-09 0000822746 2021-11-08 2021-11-09 0000822746 AMNI:LetterAgreementMember 2021-11-08 2021-11-09 0000822746 AMNI:BoardOfAdvisorsMember AMNI:LetterAgreementMember 2021-11-09 0000822746 AMNI:USNGLetterAgreementMember 2021-11-09 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2023-01-01 2023-03-31 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2022-01-01 2022-03-31 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2023-03-31 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2021-11-08 2021-11-09 0000822746 AMNI:LetterAgreementMember 2023-03-31 0000822746 AMNI:ExercisePriceThreeMember 2023-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2021-11-09 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-11-09 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2021-11-09 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2021-11-09 0000822746 us-gaap:WarrantMember 2021-11-09 0000822746 AMNI:ConvertiableNotesPayableOneMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiableNotesPayableOneMember 2022-01-01 2022-03-31 0000822746 AMNI:ConvertiableNotesPayableTwoMember 2023-01-01 2023-03-31 0000822746 AMNI:ConvertiableNotesPayableTwoMember 2022-01-01 2022-03-31 0000822746 AMNI:TexasandWyomingWellsMember 2023-03-31 0000822746 AMNI:TexasandWyomingWellsMember 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2022-01-01 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2023-03-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0000822746 us-gaap:WarrantMember 2022-12-31 0000822746 us-gaap:WarrantMember 2021-12-31 0000822746 AMNI:ConsultantsMember 2023-03-31 0000822746 2012-10-01 2012-10-31 0000822746 2012-10-31 0000822746 AMNI:CambrianConsultantsAmericaIncMember 2014-12-07 2014-12-08 0000822746 AMNI:TorreyHillsCapitalIncMember 2014-08-14 2014-08-15 0000822746 AMNI:ConsultingAgreementMember 2013-10-17 2013-10-18 0000822746 AMNI:ConsultingAgreementMember 2013-01-01 2013-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2023-01-13 2023-01-13 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-16 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-15 2021-03-16 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-25 2021-03-26 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-26 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:MarchTwoThousandTwentyOneIssuanceMember 2023-01-01 2023-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:MarchTwoThousandTwentyOneIssuanceMember 2022-01-01 2022-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:MarchTwoThousandTwentyOneIssuanceMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-01-01 2021-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2023-01-01 2023-03-31 0000822746 AMNI:OzarkCapitalLLCMember 2021-03-25 2021-03-26 0000822746 AMNI:OzarkCapitalLLCMember 2021-03-26 0000822746 AMNI:OzarkCapitalLLCMember 2022-12-31 0000822746 AMNI:OzarkCapitalLLCMember 2023-01-01 2023-03-31 0000822746 AMNI:OzarkCapitalLLCMember 2022-01-01 2022-03-31 0000822746 AMNI:OzarkCapitalLLCMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-06-12 2022-06-15 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-06-15 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:JuneTwoThousandTwentyTwoIssuanceMember 2023-01-01 2023-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:JuneTwoThousandTwentyTwoIssuanceMember 2022-01-01 2022-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:JuneTwoThousandTwentyTwoIssuanceMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-08-01 2022-08-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-08-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:AugustSeptemberTwoThousandTwentyTwoIssuanceMember 2023-01-01 2023-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:AugustSeptemberTwoThousandTwentyTwoIssuanceMember 2022-01-01 2022-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:AugustSeptemberTwoThousandTwentyTwoIssuanceMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-01-01 2022-03-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember us-gaap:WarrantMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2023-03-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2022-12-31 0000822746 AMNI:SeriesBConvertiblePreferredStockMember us-gaap:SubsequentEventMember 2023-05-03 0000822746 us-gaap:SeriesBPreferredStockMember us-gaap:SubsequentEventMember 2023-05-03 0000822746 AMNI:SeriesBConvertiblePreferredStockMember us-gaap:SubsequentEventMember 2023-05-03 2023-05-04 0000822746 AMNI:SeriesBConvertiblePreferredStockMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2023-05-03 2023-05-04 0000822746 AMNI:SeriesBConvertiblePreferredStockMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2023-05-04 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:SeriesBPreferredStockMember us-gaap:SubsequentEventMember 2023-05-05 2023-05-05 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:ConvertibleCommonStockMember us-gaap:SubsequentEventMember 2023-05-05 2023-05-05 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:SubsequentEventMember 2023-05-05 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:SubsequentEventMember 2023-05-05 2023-05-05 0000822746 AMNI:OzarkCapitalLLCMember 2023-03-31 0000822746 AMNI:OzarkCapitalLLCMember 2022-12-31 0000822746 AMNI:OzarkCapitalLLCMember AMNI:ClassAConvertiblePreferredStockMember 2023-01-01 2023-03-31 0000822746 AMNI:OzarkCapitalLLCMember AMNI:ClassAConvertiblePreferredStockMember 2022-01-01 2022-03-31 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0000822746 AMNI:OzarkCapitalLLCMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2023-05-03 2023-05-04 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember us-gaap:SubsequentEventMember 2023-05-05 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2022-10-29 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2022-09-15 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:SubsequentEventMember 2023-05-05 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnSeptemberMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnSeptemberMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnJuneMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnJuneMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2023-01-10 0000822746 AMNI:ConvertiblePromissoryNotesPayableDueOnOctoberMember 2023-05-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:acre utr:bbl

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________.

 

Commission File Number: 000-17204

 

AMERICAN NOBLE GAS INC

(Exact name of registrant as specified in its charter)

 

Nevada   87-3574612

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

15612 College Blvd, Lenexa, KS 66219

(Address of principal executive offices) (Zip Code)

 

(913) 955-0532

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
   

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of Exchange Act.

 

  Large accelerated filer ☐   Accelerated filer ☐
  Non-accelerated filer   Smaller reporting company
      Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of June 8, 2023, the registrant had 22,424,515 shares of common stock, $0.0001 par value per share outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

  Page
PART I - Financial Information  
Item 1. Financial Statements  
Condensed Balance Sheets: March 31, 2023 (Unaudited) and December 31, 2022 3
Condensed Statements of Operations: Three months ended March 31, 2023 and 2022 (Unaudited) 4
Condensed Statements of Changes in Stockholders’ Deficit: Three months ended March 31, 2023 and 2022 (Unaudited) 5
Condensed Statements of Cash Flows: Three months ended March 31, 2023 and 2022 (Unaudited) 6
Notes to Condensed Financial Statements (Unaudited) 7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 39
Item 3. Quantitative and Qualitative Disclosures About Market Risk 53
Item 4. Controls and Procedures 53
PART II - Other Information
Item 1. Legal Proceedings 54
Item 1A Risk Factors 54
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 54
Item 3. Defaults Upon Senior Securities 54
Item 4. Mine Safety Disclosures 55
Item 5. Other Information 55
Item 6. Exhibits 55
Signatures 56

 

2
 

 

PART I - FINANCIAL INFORMATION

 

AMERICAN NOBLE GAS INC

Condensed Balance Sheets

 

   

March 31, 2023

    December 31, 2022  
    (unaudited)        
ASSETS                
Current assets:                
Cash and cash equivalents   $ 2,008     $ 10,163  
Accrued receivable     55,658       47,423  
Prepaid expenses     9,062       12,617  
                 
Total current assets     66,728       70,203  
Oil and gas properties and equipment:                
Oil and gas properties and equipment     1,217,016       1,217,016  
Accumulated depreciation, depletion and impairment     (1,131,740 )     (1,128,329 )
                 
Property and equipment, net     85,276       88,687  
                 
Investment in unconsolidated subsidiary – GMDOC, LLC     1,141,274       1,101,461  
                 
Total assets   $ 1,293,278     $ 1,260,351  
                 
LIABILITIES AND STOCKHOLDERS’ DEFICIT                
Current liabilities:                
Accounts payable   $ 1,570,855     $ 1,387,893  
Accrued liabilities     1,159,403       1,159,403  
Accrued interest - $1,713 and $1,501 to related parties as of March 31, 2023 and December 31, 2022, respectively     108,785       244,038  
Accrued dividends     140,065       77,124  
Warrant derivative liability     209,802       577,269  
Convertible notes payable, net of unamortized discount     1,266,204       1,312,500  
                 
Total current liabilities     4,455,114       4,758,227  
                 
Asset retirement obligations     1,733,704       1,732,486  
Convertible promissory notes, net of unamortized discount - related parties     28,665       28,665  
                 
Total liabilities     6,217,483       6,519,378  
Commitments and contingencies (Note 12)     -        -   
                 
Stockholders’ deficit:                
Preferred stock; par value $0.0001 per share, 10,000,000 shares authorized; Series A Convertible Preferred Stock – 27,778 shares authorized with stated/liquidation value of $100 per share, 25,526 and 25,526 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively     3       3  
Common Stock, par value $0.0001 per share, 500,000,000 shares authorized, 22,424,515 shares issued and outstanding at March 31, 2023 and 21,924,515 shares issued and outstanding at December 31, 2022     2,242       2,192  
Additional paid-in capital     117,602,298       117,369,198  
Accumulated deficit     (122,528,748 )     (122,630,420 )
Total stockholders’ deficit     (4,924,205 )     (5,259,027 )
Total liabilities and stockholders’ deficit   $ 1,293,278     $ 1,260,351  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3
 

 

AMERICAN NOBLE GAS INC

Condensed Statements of Operations

(unaudited)

 

   2023   2022 
   Three months ended March 31, 
   2023   2022 
         
Revenues  $8,924   $25,305 
           
Operating expenses:          
Oil and gas lease operating expense   29,605    86,536 
Depreciation, depletion and impairment   3,411    30,834 
Accretion of asset retirement obligation   1,218    279 
Oil and gas production related taxes       28 
Other general and administrative expenses   411,848    368,706 
           
Total operating expenses   446,082    486,383 
           
Operating loss   (437,158)   (461,078)
           
Other income (expense):          
Equity in earnings of unconsolidated subsidiary – GMDOC, LLC   39,813     
Interest expense   (37,412)   (93,556)
Gain on extinguishment of convertible notes payable   168,962     
Change in warrant derivative fair value   367,467     
           
Total other income (expense)   538,830    (93,556)
           
Income (loss) before income taxes   101,672    (554,634)
Income tax (expense) benefit        
           
Net income (loss)   101,672    (554,634)
           
Convertible preferred stock dividends   (62,941)   (52,861)
           
Net income (loss) attributable to common stockholders  $38,731   $(607,495)
           
Basic and diluted net loss per share:          
Basic  $0.00   $(0.03)
Diluted  $0.00   $(0.03)
           
Weighted average shares outstanding – basic   22,357,099    19,213,560 
Weighted average shares outstanding – diluted   22,357,099    19,213,560 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4
 

 

AMERICAN NOBLE GAS INC

Condensed Statements of Changes in Stockholders’ Deficit

 

   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
   Preferred Stock   Common Stock   Additional
Paid-in
   Accumulated   Stockholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance, December 31, 2021   22,076   $2    19,012,015   $1,901   $115,522,952   $(118,690,345)  $   (3,165,490)
                                    
Stock-based compensation                   229,906        229,906 
                                    
Issuance of common stock pursuant to conversion of convertible preferred stock   (800)       250,000    25    (25)        
                                    
Accrual of preferred stock dividends                   (52,861)       (52,861)
                                    
Net loss                       (554,634)   (554,634)
                                    
Balance, March 31,
2022
   21,276   $2   19,262,015   $1,926   $115,699,972   $(119,244,979)  $(3,543,079)
                                    
Balance, December 31, 2022   25,526   $3    21,924,515   $2,192   $117,369,198   $(122,630,420)  $(5,259,027)
                                    
Stock-based compensation                   246,091        246,091 
                                    
Issuance of common stock upon conversion
convertible notes payable and accrued interest
           500,000    50    49,950        50,000 
                                    
Accrual of preferred stock dividends                   (62,941)       (62,941)
                                    
Net income                       101,672    101,672 
                                    
Balance, March 31, 2023   25,526   $3    22,424,515   $2,242   $117,602,298   $(122,528,748)  $(4,924,205)

 

The accompanying notes are an integral part of these unaudited co0ndensed financial statements.

 

5
 

 

AMERICAN NOBLE GAS INC

Condensed Statements of Cash Flows

 

   2023   2022 
  

For the three months ended

March 31,

 
   2023   2022 
Cash flows from operating activities:          
Net income (loss)  $101,672   $(554,634)
Adjustments to reconcile net loss to net cash used in operating activities:          
Equity in earnings of unconsolidated subsidiary – GMDOC, LLC   (39,813)    
Change in fair value of derivative liability   (367,467)    
Stock-based compensation   246,091    229,906 
Gain on extinguishment of convertible notes payable   (168,962)    
Depreciation, depletion and amortization   3,411    30,834 
Accretion of asset retirement obligations   1,218    279 
Amortization of discount on convertible notes payable       80,667 
Change in operating assets and liabilities:          
Increase in accounts receivable   (8,235)   (3,799)
Decrease in prepaid expenses   3,555    3,500 
Increase in accounts payable   182,962    162,826 
Increase in accrued interest   37,413    210 
           
Net cash used in operating activities   (8,155)   (50,211)
           
Cash flows from investing activities:          
Investment in oil and gas properties and equipment       (9,134)
Net cash used in investing activities       (9,134)
           
Cash flows from financing activities:          
Cash dividends paid on preferred stock       (52,861)
Net cash provided by financing activities       (52,861)
           
Net decrease in cash and cash equivalents   (8,155)   (112,206)
           
Cash and cash equivalents:          
Beginning   10,163    260,590 
Ending  $2,008   $148,384 
Supplemental cash flow information:          
Cash paid for interest  $   $12,679 
Cash paid for taxes  $   $ 
           
Supplemental disclosure of non-cash investing and financing activities:          
Accrual of dividends on Series A Convertible Preferred Stock  $62,941   $ 
Issuance of common stock upon conversion of convertible notes payable and accrued interest  $50,000   $ 
Conversion of Series A Convertible Preferred Stock to Common Stock  $   $25 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

6
 

 

AMERICAN NOBLE GAS, INC.

Notes to Unaudited Condensed Financial Statements

March 31, 2023

 

Note 1 – Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies

 

Unaudited Interim Financial Information

 

American Noble Gas, Inc. has prepared the accompanying condensed financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. These financial statements are unaudited and, in our opinion, include all adjustments consisting of normal recurring adjustments and accruals necessary for a fair presentation of our condensed balance sheets, statements of operations, statements of stockholders’ deficit and cash flows for the periods presented. Operating results for the periods presented are not necessarily indicative of the results that may be expected for the remainder of 2023 due to various factors. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been omitted in accordance with the rules and regulations of the SEC. These condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes in Item 8, “Financial Statements and Supplementary Data,” of our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC.

 

Nature of Operations

 

The Company has assessed various opportunities and strategic alternatives involving the acquisition, exploration and development of oil and gas oil producing properties in the United States, including the possibility of acquiring businesses or assets that provide support services for the production of oil and gas in the United States.

 

As a result, we are now involved with the following oil and gas producing properties:

 

Central Kansas Uplift - On April 1, 2021, we completed the acquisition of the Central Kansas Uplift Properties, for a purchase price of $900,000. The Central Kansas Uplift Properties include the production and mineral rights/leasehold for oil and gas properties, subject to overriding royalties to third parties, in the Central Kansas Uplift geological formation covering over 11,000 contiguous acres (the “Properties”). The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

 

We commenced rework of the existing production wells after completion of the acquisition of the Properties and have performed testing and evaluation of the existence of noble gas reserves on the Properties including helium, argon and other rare earth minerals/gases. Testing of the Properties for noble gas reserves has provided encouraging but not conclusive results and the Company has yet to determine the possibility of commercializing the noble gas reserves on the Properties. The Company plans to assess the Properties’ existing oil and gas reserves while continuing the evaluation of the existence of new oil and gas zones and other mineral reserves and specifically the noble gas reserves that the Properties may hold.

 

During the year ended December 31, 2022, the Company changed its strategy regarding the Central Kansas Uplift considering the reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of March 31, 2023 and December 31, 2022 and is considering the deepening of the conventional wells on the property to explore for helium and other noble gases that may be present in deeper producing zones. Accordingly, the Company has recorded an impairment charge of $712,812 to reduce the capitalized tangible and intangible costs related to its Central Kansas Uplift properties to zero as of March 31, 2023 and December 31, 2022.

 

Hugoton Gas Field Farm-Out - On April 4, 2022, the Company acquired a 40% participation in a Farmout Agreement by and between Sunflower Exploration, LLC as the Farmee and Scout Energy Partners as Farmor (“Scout”) with regards to its oil and gas interests in the Hugoton Gas Field, located in Haskell and Finney Counties, Kansas. The Company has joined three other parties to explore for and develop potential oil, natural gas, noble gases and brine minerals on the properties underlying the Farmout Agreement (collectively the “Hugoton JV”).

 

7
 

 

The Farmout Agreement covers drilling and completion of up to 50 wells, with the first exploratory well spudded on May 7, 2022. The Hugoton JV will utilize Scout’s existing infrastructure assets including water disposal, gas gathering and helium processing. The Farmout Agreement provides the Hugoton JV with rights to take in-kind and market its share of helium at the tailgate of Jayhawk Gas Plant, which will enable the Hugoton JV to market and sell the helium produced at prevailing market prices.

 

The Hugoton JV also acquired the right to all brine minerals subject to a ten percent (10%) royalty to Scout, across Finney and Haskell Counties. Brine minerals are harvested from the formation water produced from active, and to be drilled, oil and gas wells and may include a variety of dissolved minerals including bromine and iodine. The Hugoton JV plans to target brine minerals with commercial quantities of bromine and iodine. The Company through the Hugoton JV is currently developing proprietary technology to recover brine minerals, particularly with respect to bromine, which is well underway and has demonstrated recovery efficiency and is expected to be available for use in existing and future development wells.

 

The Hugoton JV believes that its unconventional theory has not previously been targeted for exploration by historical operations in the field. The initial exploratory well was spud on May 7, 2022 near Garden City, Kansas, with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves. The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production and sales of natural gas, natural gas liquids and helium on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout.

 

The Company performed the ceiling test to assess potential impairment of the capitalized costs relative to its Hugoton Gas Field Project. The ceiling test indicated an impairment charge of $192,762 was required to reduce the total capitalized costs to $88,687 as of December 31, 2022. Accordingly, the Company has recorded an impairment charge of $192,762 to reduce the capitalized tangible and intangible costs related to its Hugoton Gas Field properties to $88,687 as of December 31, 2022. The Company recorded an addition to depreciation and amortization expense of $3,411 during the three months ended March 31, 2023.

 

Investment in GMDOC, LLC - On May 3, 2022, the Company entered into an operating agreement (the “Operating Agreement”) pursuant to which the Company acquired 17 (or 60.7143%) of 28 limited liability membership interests (the “Interests”) in GMDOC, LLC, a Kansas limited liability company (“GMDOC”), for an aggregate purchase price of $4,037,500, and was subsequently admitted as a member of GMDOC.

 

The Company paid the cash contribution for the membership interests of $850,000, during May 2022. The remainder of the Company’s capital contribution, or $3,187,500, was financed by the Bank Loan (as defined below).

 

GMDOC had previously acquired 70% of the working interests (the “Acquisition”) in certain oil and gas leases (the “GMDOC Leases”) from Castelli Energy, L.L.C., an Oklahoma limited liability company (“Castelli”). The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC Leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis.

 

GMDOC is managed by two members: Darrah Oil Company, LLC, and Grand Mesa Operating Company, (collectively the “Managing Members”), which also serve as the operating companies under the GMDOC Leases.

 

Going Concern

 

The Company has incurred losses from operations, has a stockholders’ deficit, incurred net cash used in operating activities and has a significant working capital deficit as of and for the three months ended March 31, 2023 and as of and for the years ended December 31, 2022 and 2021. The Company must raise substantial amounts of debt and equity capital from other sources in the future in order to fund (i) the development of the Properties acquired on April 1, 2021; (ii) our obligations for exploration and development under the Hugoton Farmout Agreement; (iii) normal day-to-day operations and corporate overhead; and (iv) outstanding debt and other financial obligations as they become due, as described below. Most of the Company’s outstanding debt and other financial obligations are currently past due and the Company must negotiate forbearance and/or restructuring agreements with the holders of such debt. These are substantial operational and financial issues that must be successfully addressed during 2023 and beyond.

 

8
 

 

The Company has made substantial progress in resolving many of its existing financial obligations and acquiring oil and gas producing properties to deploy its new operational strategy during the period through March 31, 2023.

 

The Company will have significant financial commitments executing its planned exploration and development of the Properties and the Hugoton Gas Field. The Company may find it necessary to raise substantial amounts of debt or equity capital to fund such exploration and development activities and may seek offers from industry operators and other third parties for interests in the Properties in exchange for cash and a carried interest in exploration and development operations or other joint venture arrangement. There can be no assurance that it will be able to obtain such new funding or be able to reach agreements with industry operators and other third parties or on what terms.

 

Due to the uncertainties related to the foregoing matters, there exists substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financials are issued. The unaudited condensed financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

 

Revenue Recognition

 

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” and the series of related accounting standard updates that followed, using the modified retrospective method of adoption. Adoption of the ASU did not require an adjustment to the opening balance of equity and did not change the Company’s amount and timing of revenues.

 

The Company’s revenues are primarily derived from its interests in the sale of oil and natural gas production. To date, such revenues have only included the sale of oil and natural gas however the Company expects to begin generating more substantial revenues from the sale of noble gases in the future. The Company recognizes revenue from its interests in the sales of oil and gas in the period that its performance obligations are satisfied. Performance obligations are satisfied when the customer obtains control of product, when the Company has no further obligations to perform related to the sale, when the transaction price has been determined and when collectability is probable. The sales of oil and gas are made under contracts which the third-party operators of the wells have negotiated with customers, which typically include variable consideration that is based on pricing tied to local indices and volumes delivered in the current month. The Company receives payment from the sale of oil and gas production from one to three months after delivery. At the end of each month when the performance obligation is satisfied, the variable consideration can be reasonably estimated and amounts due from customers are accrued in trade receivables, net in the balance sheets. Variances between the Company’s estimated revenue and actual payments are recorded in the month the payment is received, however, differences have been and are insignificant. The Company’s oil is typically sold at delivery points under contracts terms that are common in our industry.

 

Cash and Cash Equivalents

 

For purposes of reporting cash flows, cash consists of cash on hand and demand deposits with financial institutions. The Company’s policy is that all highly liquid investments with an original maturity of three months or less when purchased would be cash equivalents and would be included along with cash as cash and equivalents.

 

The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with several financial institutions if necessary to remain below the federally insured limit of $250,000 per bank. At March 31, 2023 and December 31, 2022, the uninsured balance amounted to $-0- and $-0-, respectively.

 

9
 

 

Convertible Instruments

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)” which is intended to reduce complexity in applying GAAP to certain financial instruments with characteristics of liabilities and equity. The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in Accounting Standards Codification (“ASC”) 470-20, Debt: Debt with Conversion and Other Options that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. The guidance in ASC 470-20 applies to convertible instruments for which the embedded conversion features are not required to be bifurcated from the host contract and accounted for as derivatives. In addition, the amendments revise the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. These amendments are expected to result in more freestanding financial instruments qualifying for equity classification (and, therefore, not accounted for as derivatives), as well as fewer embedded features requiring separate accounting from the host contract. The amendments in ASU 2020-06 further revise the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares.

 

The Company early adopted ASU 2020-06 effective January 1, 2021 and applied ASU 2020-06 to all outstanding financial instruments as of January 1, 2021.

 

Conversion options that contain variable settlement features such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract generally result in their bifurcation from the host instrument.

 

Derivative Instruments

 

The Company accounts for derivative instruments or hedging activities under the provisions of ASC 815 Derivatives and Hedging. ASC 815 requires the Company to record derivative instruments at their fair value. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in other comprehensive earnings (loss) and are recognized in the statement of earnings when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges, if any, are recognized in earnings. Changes in the fair value of derivatives that do not qualify for hedge treatment are recognized in earnings.

 

The purpose of hedging is to provide a measure of stability to the Company’s cash flows in an environment of volatile oil and gas prices and to manage the exposure to commodity price risk. As of March 31, 2023 and December 31, 2022 and during the periods then ended, the Company had no oil and natural gas derivative arrangements outstanding.

 

As a result of certain terms, conditions and features included in certain common stock purchase warrants issued by the Company (Notes 4 and 11), those warrants were required to be accounted for as derivatives at estimated fair value, with changes in fair value recognized in operations.

 

Fair Value of Financial Instruments

 

The carrying values of the Company’s accounts payable, accrued liabilities and short-term notes represent the estimated fair value due to the short-term nature of the accounts.

 

In accordance with ASC Topic 820 — Fair Value Measurements and Disclosures (“ASC 820”), the Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business.

 

10
 

 

ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

 

  Level 1 — Quoted prices in active markets for identical assets and liabilities.
       
  Level 2 — Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities).
       
  Level 3 — Significant unobservable inputs (including the Company’s own assumptions in determining the fair value.

 

The estimated fair value of warrant derivative liabilities, which are related to detachable warrants issued in connection with the Series A Convertible Preferred Stock, par value $0.001 per share (the “Series A Convertible Preferred Stock”) were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock, par value $0.001 per Share (the “Common Stock”) and current interest rates. The fair values for the warrant derivatives as of March 31, 2023 and December 31, 2022 were classified under the fair value hierarchy as Level 3.

 

The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022:

March 31, 2023  Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $209,802   $209,802 
   $   $   $209,802   $209,802 

 

December 31, 2022  Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $577,269   $577,269 
   $   $   $577,269   $577,269 

 

There were no changes in valuation techniques or reclassifications of fair value measurements between Levels 1, 2 or 3 during the three months ended March 31, 2023 and 2022.

 

Management Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Significant estimates include, but are not limited to, oil and gas reserves; depreciation, depletion and amortization of proved oil and gas properties; future cash flows from oil and gas properties; impairment of long-lived assets; fair value of derivatives; asset retirement obligations, our control over equity method investments, fair value of equity compensation; warrants issued in connection with convertible debt; the realization of deferred tax assets; fair values of assets acquired and liabilities assumed in business combinations.

 

Oil and gas properties

 

Central Kansas Uplift Properties - On April 1, 2021, we completed the acquisition of the Properties, under the terms of the Asset Purchase Agreement, for a purchase price of $900,000. The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

 

11
 

 

The Company has performed workovers of the wells subsequent to the Properties purchase which was necessary to put the lease back into production status. Therefore, these tangible and intangible workover costs were expensed as lease operating expenses rather than capitalized in the full cost pool through December 31, 2022. In addition, the Company is currently evaluating the Properties for oil and gas reserves and specifically the potential for noble gas reserves such as helium, argon and krypton. Based on these evaluations, the Company may redirect its efforts to the production of noble gases rather than crude oil on the Properties. These noble gas evaluation costs have also been expensed as lease operating costs through March 31, 2023.

 

Hugoton Gas Field Farm-Out -The first exploratory well commenced on May 7, 2022 near Garden City, Kansas with a goal to evaluate its unconventional theory of where substantial oil, natural gas and noble gases may be present in the Hugoton Gas Field. The initial well in which the Company has acquired a 40% participation together with three other venture partners was spud on May 7, 2022 with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves.

 

The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout.

 

Full Cost Accounting

 

The accounting for, and disclosure of, oil and gas producing activities require that we choose between two GAAP alternatives: the full cost method or the successful efforts method. We adopted and use the full cost method of accounting, which involves capitalizing all exploration, exploitation, development and acquisition costs. Once we incur costs, they are recorded in the depletable pool of proved properties or in unproved properties, collectively, the full cost pool. Our unproved property costs, which include unproved oil and gas properties, properties under development, and major development projects, were zero as of March 31, 2023 and December 31, 2022, and are not subject to depletion. We review our unproved oil and gas property costs on a quarterly basis to assess for impairment and transfer unproved costs to proved properties as a result of extensions or discoveries from drilling operations or determination that no proved reserves are attributable to such costs. We expect these costs to be evaluated in one to seven years and transferred to the depletable portion of the full cost pool during that time. The full cost pool is comprised of intangible drilling costs, lease and well equipment and exploration and development costs incurred plus acquired proved and unproved leaseholds.

 

When we acquire significant amounts of undeveloped acreage, we capitalize interest on the acquisition costs in accordance with FASB ASC Subtopic 835-20 for Capitalization of Interest. When the unproved property costs are moved to proved developed and undeveloped oil and gas properties, or the properties are sold, we cease capitalizing interest.

 

Capitalized costs to acquire oil and natural gas properties are depreciated and depleted on a units-of-production basis based on estimated proved reserves. Capitalized costs of exploratory wells and development costs are depreciated and depleted on a units-of-production basis based on estimated proved developed reserves. Under this method, the sum of the full cost pool, excluding the book value of unproved properties, and all estimated future development costs are divided by the total estimated quantities of proved reserves. This rate is applied to our total production for the quarter, and the appropriate expense is recorded. Support equipment and other property, plant and equipment related to oil and gas producing activities, as well as property, plant and equipment unrelated to oil and gas producing activities, are recorded at cost and depreciated on a straight-line basis over the estimated useful lives of the assets.

 

Sales, dispositions and other oil and gas property retirements are accounted for as adjustments to the full cost pool, with no recognition of gain or loss, unless the disposition would significantly alter the amortization rate and/or the relationship between capitalized costs and Proved Reserves.

 

12
 

 

Pursuant to Rule 4-10(c)(4) of Regulation S-X, at the end of each quarterly period, companies that use the full cost method of accounting for their oil and gas properties must compute a limitation on capitalized costs, or ceiling test. The ceiling test involves comparing the net book value of the full cost pool, after taxes, to the full cost ceiling limitation defined below. In the event the full cost ceiling is less than the full cost pool, we must record a ceiling test write-down of our oil and gas properties to the value of the full cost ceiling. The full cost ceiling limitation is computed as the sum of the present value of estimated future net revenues from our proved reserves by applying average prices as prescribed by the SEC Release No. 33-8995, less estimated future expenditures (based on current costs) to develop and produce the proved reserves, discounted at 10%, plus the cost of properties not being amortized and the lower of cost or estimated fair value of unproved properties included in the costs being amortized, net of income tax effects.

 

The ceiling test is computed using the simple average spot price for the trailing twelve-month period using the first day of each month. The trailing twelve-month reference price was $94.14 per barrel for the West Texas Intermediate oil at Cushing, Oklahoma through December 31, 2022. This reference price for oil is further adjusted for quality factors and regional differentials to derive estimated future net revenues. Under full cost accounting rules, any ceiling test write-downs of oil and gas properties may not be reversed in subsequent periods. We recognized an impairment charge of $905,574 as of December 31, 2022 which is attributable to changing our strategy to exploring for noble gases and away from crude oil production at our Central Kansas Uplift properties which resulted in a large decrease in estimated future cash flows.

 

The ceiling test calculation is based upon estimates of proved reserves. There are numerous uncertainties inherent in estimating quantities of proved reserves, in projecting the future rates of production and in the timing of development activities. The accuracy of any reserve estimate is a function of the quality of available data and of engineering and geological interpretation and judgment. Results of drilling, testing and production subsequent to the date of the estimate may justify revision of such estimate. Accordingly, reserve estimates are often different from the quantities of oil and gas that are ultimately recovered.

 

Equity Method Investments

 

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of the net income or loss of these investees is included in our Statements of Operations. Judgment regarding the level of influence over each equity method investment includes considering key factors such as the Company’s ownership interest, legal form of the investee, representation on the board of directors, participation in policy-making decisions and material intra-entity transactions.

 

The Company evaluates equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by the Company when reviewing an equity method investment for impairment include the length of time and the extent to which the fair value of the equity method investment has been less than cost, the investee’s financial condition and near-term prospects and the intent and ability to hold the investment for a period of time sufficient to allow for anticipated recovery. An impairment that is other-than temporary is recognized in the period identified.

 

The Company accounts for distributions received from equity method investees under the “nature of the distribution” approach. Under this approach, distributions received from equity method investees are classified on the basis of the nature of the activity or activities of the investee that generated the distribution as either a return on investment (classified as cash inflows from operating activities) or a return of investment (classified as cash inflows from investing activities).

 

Issuance of Debt Instruments With Detachable Stock Purchase Warrants

 

Proceeds from the issuance of a debt instrument with stock purchase warrants (detachable call options) are allocated to the two elements based on the relative fair values of the debt instrument without the warrants and of the warrants themselves at time of issuance. The portion of the proceeds allocated to the warrants are recorded as additional paid-in capital. The remainder of the proceeds are allocated to the debt instrument portion of the transaction. Such issuances generally result in a discount (or, occasionally, a reduced premium) relative to the debt instrument, which is amortized to interest expense using the effective interest rate method.

 

13
 

 

Asset Retirement Obligations

 

The Company records estimated future asset retirement obligations pursuant to the provisions of ASC 410. ASC 410 requires entities to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred with a corresponding increase in the carrying amount of the related long-lived asset. Subsequent to its initial measurement, the asset retirement liability is required to be accreted each period. The Company’s asset retirement obligations consist of costs related to the plugging of wells, the removal of facilities and equipment, and site restoration on oil and gas properties.

 

During April 2021, the Company acquired the Properties and assumed the related asset retirement obligation existing at the date of acquisition. The asset retirement obligation assumed for the Properties relates to the plug and abandonment costs when the wells acquired are no longer useful. The Company determined the value of the liability by obtaining quotes for this service and estimated the increased costs that the Company will face in the future. We then discounted the future value based on an intrinsic interest rate that is appropriate for us. If costs rise more than what we have expected there could be additional charges in the future; however, we monitor the costs of the abandoned wells and we will adjust this liability if necessary.

 

As of December 31, 2012, the Company had divested all of its domestic oil properties that contained operating and abandoned wells in Texas, Colorado and Wyoming. The Company may have obligations related to the divestiture of certain abandoned non-producing domestic leasehold properties should the new owner not perform its obligations to reclaim abandoned wells in a timely manner. Management believes the Company has been relieved from asset retirement obligation related to Infinity-Texas because of the sale of its Texas oil and gas properties in 2011 and its sale of 100% of the stock in Infinity-Texas in 2012. The Company has recognized an additional liability of $734,897 related to its former Texas oil and gas producing properties (included in asset retirement obligations) to recognize the potential personal liability of the Company and its officers for the Infinity-Texas oil and gas properties should the new owner not perform its obligations to reclaim abandoned wells in a timely manner. In addition, management believes the Company has been relieved from asset retirement obligations related to Infinity-Wyoming because of the sale of its Wyoming and Colorado oil and gas properties in 2008; however, the Company has recognized since 2012 an additional liability of $981,106 related to its former Wyoming and Colorado oil and gas producing properties (included in asset retirement obligations) to recognize the potential liability of the Company and its officers should the new owner not perform its obligations to reclaim abandoned wells in a timely manner.

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes. This method requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between financial accounting bases and tax bases of assets and liabilities. The tax benefits of tax loss carryforwards and other deferred taxes are recorded as an asset to the extent that management assesses the utilization of such assets to be more likely than not. Management routinely assesses the realizability of the Company’s deferred income tax assets, and a valuation allowance is recognized if it is determined that deferred income tax assets may not be fully utilized in future periods. Management considers future taxable earnings in making such assessments. Numerous judgments and assumptions are inherent in the determination of future taxable earnings, including such factors as future operating conditions. When the future utilization of some portion of the deferred tax asset is determined not to be more likely than not, a valuation allowance is provided to reduce the recorded deferred tax asset. When the Company can project that a portion of the deferred tax asset can be realized through application of a portion of tax loss carryforward, the Company will record that utilization as a deferred tax benefit and recognize a deferred tax asset in the same amount. There can be no assurance that facts and circumstances will not materially change and require the Company to adjust its deferred income tax asset valuation allowance in a future period. The Company recognized a deferred tax asset, net of valuation allowance, of $-0- at March 31, 2023 and December 31, 2022.

 

14
 

 

The Company is potentially subject to taxation in many jurisdictions, and the calculation of income tax liabilities (if any) involves dealing with uncertainties in the application of complex income tax laws and regulations in various taxing jurisdictions. It recognizes certain income tax positions that meet a more-likely-than not recognition threshold. If the Company ultimately determines that the payment of these liabilities will be unnecessary, it will reverse the liability and recognize an income tax benefit. No liability for unrecognized tax benefit was recorded as of March 31, 2023 and December 31, 2022.

 

Stock-based compensation

 

The Company applies ASC 718, Stock Compensation, which requires companies to recognize compensation expense for share-based payments based on the estimated fair value of the awards. ASC 718 also requires tax benefits relating to the deductibility of increases in the value of equity instruments issued under share-based compensation arrangements to be presented as financing cash inflows in the statement of cash flows. Compensation cost is recognized based on the grant-date fair value for all share-based payments granted and is estimated in accordance with the provisions of ASC 718.

 

Related Party Transactions

 

The Company’s financial statements include disclosures of material related party transactions, other than compensation arrangements, expense allowances and similar items in the ordinary course of business. Disclosure of related party transactions include: 1) the nature of the relationships involved, 2) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements, 3) the dollar amounts of the transactions for each periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period, and 4) amounts due from or to related parties as of the date of each balance sheet presented and if not otherwise apparent,5) the terms of settlement.

 

Basic and Diluted Income (Loss) Per Share

 

Net income (loss) per share is calculated in accordance with FASB ASC 260, Earnings Per Share, for the periods presented. Basic net loss per share is based upon the weighted average number of shares of Common Stock outstanding. Diluted net earnings (loss) per share is based on the assumption that all dilutive convertible shares, warrants and stock options were converted or exercised or excluded from the calculations if their inclusion would be antidilutive. Dilution is computed by applying the if-converted/treasury stock method. Under this method, options and warrants are assumed exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase shares of Common Stock at the average market price during the period. The Company has outstanding convertible notes payable and Series A Convertible Preferred Stock both of which are potentially dilutive. Such potential dilutive effect is included in diluted earnings (loss) per share at the beginning of the period (or at the time of issuance, if later) if they have a dilutive effect or such potentially dilutive securities are excluded from the calculations if their inclusion would be antidilutive.

 

The adoption of ASU 2020-06 requires the Company to assume share settlement when an instrument can be settled in cash or shares at the entity’s option. This applies both to convertible instruments and freestanding arrangements that could result in cash or share settlement. ASU 2020-06 also stipulates that an average market price for the period should be used in the computation of the diluted earnings (loss) per share denominator in cases when the exercise price of an instrument may change based on an entity’s share price or changes in the entity’s share price may affect the number of shares that would be used to settle a financial instrument. Lastly, an entity should use the weighted-average share count from each quarter when calculating the year-to-date weighted average share count for all potentially dilutive securities.

 

During the three months ended March 31, 2023 and 2022, the Company had outstanding the following securities that were potentially dilutive: i) Series A Convertible Preferred Stock, ii) various convertible notes payable, iii) warrants to purchase Common Stock and iv) options to purchase Common Stock. All potentially dilutive securities were considered for inclusion or exclusion from the calculation of diluted income (loss) per share for the three months ended March 31, 2023 and 2022. Any potentially dilutive security that were considered anti-dilutive were excluded from the net income (loss) per share reported for the three months ended March 31, 2023 and 2022.

 

15
 

 

Gain on Extinguishment of Liabilities / Troubled Debt Restructuring:

 

In accordance with ASC 470, the Company assesses restructuring of debt as troubled debt restructuring if the creditor for economic or legal reasons related to the debtor’s financial difficulties grant a concession to the debtor that it would not otherwise consider. The Company records a gain on restructuring of payables when it transfers its assets to a creditor to fully settle a payable. The gain is measured by the excess of the carrying amount of the payable over the fair value of the assets transferred or fair value of equity interest granted.

 

Recent Accounting Pronouncements

 

Business Combinations - In October 2021, FASB issued ASU 2021-08 Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities were recognized by the acquirer at fair value on the acquisition date. The Company adopted this ASU on January 1, 2023 and its adoption did not have a material impact on our financial statements.

 

Other accounting standards that have been issued by the FASB or other standards-setting bodies are not expected to have a material impact on the Company’s financial position, results of operations and cash flows.

 

Note 2 – Oil and Gas Properties and Equipment

 

Oil and gas properties and equipment is comprised of the following at March 31, 2023 and December 31, 2022:

   March 31, 2023  

December 31, 2022

 
Central Kansas Uplift - Oil and gas production equipment  $913,425   $913,425 
Hugoton Gas Field - Oil and gas production equipment   96,831    96,831 
Central Kansas Uplift – Leasehold costs   15,225    15,225 
Hugoton Gas Field – Leasehold costs   191,535    191,535 
           
Subtotal   1,217,016    1,217,016 
Less: Accumulated impairment   (905,574)   (905,574)
Less: Accumulated depreciation, depletion and amortization   (226,166)   (222,755)
Oil and gas properties and equipment, net  $85,276   $88,687 

 

Note 3 – Investment in unconsolidated subsidiary – GMDOC

 

A summary of the Company’s investment in unconsolidated subsidiary-GMDOC during the three months ended March 31, 2023 follows:

 

     
   Three months ended 
   March 31, 2023 
Investment in unconsolidated subsidiary-GMDOC,
at December 31, 2022
  $1,101,461 
Equity in earnings of GMDOC   39,813 
Distributions during period    
Impairment charges    
      
Investment in unconsolidated subsidiary-GMDOC at March 31, 2023  $1,141,274 

 

16
 

 

The following table presents summarized balance sheet financial information of the Company’s unconsolidated subsidiary – GMDOC as of March 31, 2023:

 

     
  

March 31,

2023

 
Assets:     
Cash  $215,466 
Accrued revenue & prepaid expenses   275,493 
Oil and gas properties and equipment, net   7,218,801 
      
Total assets  $7,709,760 
      
Liabilities and Member’s Equity:     
Accounts payable and accrued liabilities  $124,314 
General managing members advances   150,000 
Mortgage note payable, net   4,656,429 
Asset Retirement Obligations   899,271 
Member’s equity   1,879,746 
      
Total liabilities and member’s equity  $7,709,760 

 

The following table presents summarized income statement financial information of the Company’s unconsolidated subsidiary – GMDOC for the three months ended March 31, 2023:

 

     
   Three months ended 
   March 31, 2023 
     
Oil and gas revenues  $630,215 
Lease operating expenses   (308,092)
Production related taxes   (15,890)
Ad valorem taxes   (10,755)
Depreciation expense   (134,206)
Accretion of asset retirement obligation   (16,940)
General and administrative expenses   (6,682)
Interest expense   (72,075)
      
Net income   65,575 
AMGAS member’s percentage   60.7143%
      
Equity in earnings of unconsolidated subsidiary – GMDOC for the three months ended March 31, 2023  $39,813 

 

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee, GMDOC. Management’s judgment regarding its level of influence over the operations of GMDOC included considering key factors such as the Company’s ownership interest, legal form of the investee, its’ lack of participation in policy-making decisions and its’ lack of control over the day-to-day operations of GMDOC.

 

17
 

 

Note 4 – Debt Obligations

 

Debt obligations were comprised of the following at March 31, 2023 and December 31, 2022:

  

   March 31, 2023   December 31, 2022 
Notes payable:          
           
3% convertible notes payable due March 30, 2026 (the 3% Notes)  $28,665   $28,665 
8% convertible notes payable due September 30, 2023 (the October 8% Notes)   500,000    500,000 
8% convertible note payable due October 29, 2022 (the 8% Note) (in default)   100,000    100,000 
8% convertible note payable due October 29, 2022 (the Second 8% Note) (in default)   50,000    50000 
8% Convertible promissory notes payable due September 15, 2022 (the June 2022 Note) (in default)   350,000    350,000 
8% Convertible promissory notes payable due September 30, 2023 (the May 2022 Notes)   266,204    312,500 
           
Total notes payable   1,294,869    1,341,165 
Less: Long-term portion   28,665    28,665 
Notes payable, short-term  $1,266,204   $1,312,500 

 

Debt obligations become due and payable as follows:

 

     
Years ended 

Principal

balance due

 
     
2023  $1,266,204 
2024    
2025    
2026   28,665 
2027    
2028    
Total  $1,294,204 

 

3% Convertible Notes Payable due March 30, 2026

 

On March 31, 2021, the Company entered into Debt Settlement Agreements with six creditors (five of which were related parties) which extinguished accounts payable and accrued liabilities totaling $2,866,497 in exchange for the issuance of $28,665 in principal balance of 3% convertible notes payable (the “3% Notes”) with detachable warrants to purchase 5,732,994 shares of Common Stock for fifty cents ($0.50) per share (the “3% Note Warrants”). The 3% Notes allow for prepayment at any time with all principal and accrued interest becoming due and payable at maturity on March 30, 2026 (the “Maturity Date”). The 3% Notes are convertible as to principal and any accrued interest, at the option of the holder, into shares of Common Stock at any time after the issue date and prior to the close of business on the business day preceding the Maturity Date at the rate of fifty cents ($0.50) per share, subject to normal and customary adjustment.

 

8% Convertible Notes Payable due September 30, 2023

 

On October 29, 2021, the Company issued to two accredited investors (the “October 8% Note Investors”) unsecured convertible notes payable due October 29, 2022 (the “October 8% Notes”), with an aggregate principal face amount of approximately $500,000. The October 8% Notes are, subject to certain conditions, convertible into an aggregate of 1,000,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued five and one half-year Common Stock purchase warrants to purchase up to 1,500,000 shares of Common Stock at an exercise price of $0.50 per share, subject to customary adjustments (the “October 8% Note Warrants”) which are immediately exercisable. The October 8% Note Investors purchased the October 8% Notes and October 8% Note Warrants from the Company for an aggregate purchase price of $500,000 and the proceeds were used for general working capital purposes. The Company also granted the October 8% Note Investors certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the October 8% Note Warrants and the conversion of the October 8% Notes unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

The October 8% Notes all bear interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the 8% Note and the October 8% Notes shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the October 8% Notes, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the October 8% Note Investor.

 

18
 

 

The conversion of the October 8% Notes and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the October 8% Note Investors may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

The Company and the October 8% Note Investors have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

 

The Company did not pay the principal balance due on the October 8% Notes upon their original maturity on October 29, 2022 and the remaining balance remained due and payable and was therefore in technical default as of December 31, 2022. The Company reached an agreement with the two October 8% Note Investors on January 10, 2023. On January 10, 2023, the Company and the October 8% Note Holders amended each of the notes by entering into a Letter Agreement between the October 8% Note Investors and the Company. The Letter Agreement modifies the terms of the October 8% Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes.

 

The Company evaluated the terms of the January 10, 2023 Letter Agreement which amended the October 8% Notes. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the October 8% Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The amendment of the Fixed Conversion Price to $0.10 from $0.50 per share, as provided for in the Letter Agreement, would be considered substantive based on the likelihood of the conversion option being exercised in the future. Accordingly, the Company accounted for the amendment of the Notes as an extinguishment of the original Bridge Notes.

 

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment:

 

  

As of

January 10,

2023

 
Carrying value of the original convertible notes payable     
Principal balance  $500,000 
Accrued interest   120,753 
Total carrying value of original convertible note payable   620,753 
      
Less: Net present value of future cash flows on amended convertible notes payable   (516,776)
      
Gain on extinguishment of convertible notes payable  $103,977 

 

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment exceeded 10%. As a result, the Company recorded a gain on extinguishment of convertible notes payable totaling $103,977 during the three months ended March 31, 2023.

 

19
 

 

8% Convertible Notes Payable due October 29, 2022 (in default)

 

On August 30, 2021, the Company issued to an accredited investor (the “8% Note Investor”) an unsecured convertible note due October 29, 2022 (the “8% Note”), with an aggregate principal face amount of approximately $100,000. The 8% Note is, subject to certain conditions, convertible into an aggregate of 200,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued a five and one half-year Common Stock purchase warrant to purchase up to 200,000 shares of Common Stock at an exercise price of fifty cents ($0.50) per share, subject to customary adjustments (the “8% Note Warrant”) which are immediately exercisable. The 8% Note Investor purchased the 8% Note and 8% Note Warrant from the Company for an aggregate purchase price of $100,000 and the proceeds were used for general working capital purposes. The Company also granted the 8% Note Investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the 8% Note Warrant and the conversion of the 8% Note unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

The 8% Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the 8% Note shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the 8% Note, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the 8% Note Investor.

 

The conversion of the 8% Note and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the 8% Note Investor may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

The Company and the 8% Note Investor have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

 

The underlying notes and warrants contain customary events of default, representations, warranties, agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto, as applicable.

 

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including $100,000 outstanding principal balance of the 8% Note), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable were cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable.

 

The Company has accrued default interest aggregating $23,471 and $21,335 as of March 31, 2023 and December 31, 2022, respectively related to the repayment default on this note.

 

20
 

 

8% Convertible Notes Payable due October 29, 2022 (in default)

 

On October 29, 2021, the Company issued to an accredited investor (the “Second 8% Note Investor”) an unsecured convertible note payable due October 29, 2022 (the “Second 8% Notes”), with an aggregate principal face amount of approximately $50,000. The Second 8% Note is, subject to certain conditions, convertible into an aggregate of 100,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued five and one half-year Common Stock purchase warrants to purchase up to 150,000 shares of Common Stock at an exercise price of $0.50 per share, subject to customary adjustments (the “Second 8% Note Warrants”) which are immediately exercisable. The Second 8% Note Investor purchased the Second 8% Note and the Second 8% Warrants from the Company for an aggregate purchase price of $50,000 and the proceeds were used for general working capital purposes. The Company also granted the Second 8% Note Investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the Second 8% Note Warrants and the conversion of the Second 8% Note unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

The Second 8% Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the Second 8% Note shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the Second 8% Note, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the Second 8% Note Investor.

 

The conversion of the Second 8% Note and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the 8% Note Investor may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

The Company, the Second 8% Note Investor have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

 

The underlying notes and warrants contain customary events of default, representations, warranties, agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto, as applicable.

 

The Company has accrued default interest aggregating $11,736 and $10,668 as of March 31, 2023 and December 31, 2022, respectively related to the repayment default on this note.

 

21
 

 

8% Convertible Notes Payable due September 15, 2022 (in default)

 

On June 8, 2022, the Company issued to an accredited investor an unsecured convertible note due September 15, 2022 (the “June 2022 Note”), with an aggregate principal face amount of $350,000. The June 2022 Note is, subject to certain conditions, convertible into an aggregate of 700,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued a five-year Common Stock purchase warrant to purchase up to 700,000 shares of Common Stock at an exercise price of fifty cents ($0.50) per share, subject to customary adjustments (the “June 2022 Warrants”) which are immediately exercisable. The investor purchased the June 2022 Note and June 2022 Warrant from the Company for an aggregate purchase price of $350,000 and the proceeds were used for drilling and completion costs on the initial well drilled under the Hugoton Gas Field participation agreement and general working capital purposes. The Company also granted the investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares of Common Stock underlying the June 2022 Warrant and the conversion of the June 2022 Note unless the shares of the Company commence to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

The June 2022 Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to the remaining principal amount of the underlying note and any accrued and unpaid interest.

 

The underlying notes and warrants contain customary events of default, representations, warranties, agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto, as applicable.

 

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including the June 2022 Note), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable were cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable.

 

The Company has accrued default interest aggregating $15,112 and $8,208 as of March 31, 2023 and December 31, 2022, respectively related to the repayment default on these notes.

 

8% Convertible Notes Payable due September 30, 2023 (the “May 22 Notes”)

 

The Company entered into a securities purchase agreement with two accredited investors for the Company’s 8% convertible notes payable due June 29, 2022 (the “May 2022 Notes”), with an aggregate principal amount of $850,000. The May 2022 Notes are, subject to certain conditions, convertible into an aggregate of 2,125,000 shares of Common Stock, at a price of forty cents ($0.40) per share. The Company also issued an aggregate of 425,000 shares of Common Stock as commitment shares (“Commitment Shares” and, together with the May 2022 Notes and Conversion Shares, the “Securities”) to the investors as additional consideration for the purchase of the May 2022 Notes. The closing of the offering of the Securities occurred on May 13, 2022, when the investors purchased the Securities for an aggregate purchase price of $850,000. The Company has also granted the Investors certain automatic and piggy-back registration rights whereby the Company has agreed to register the resale by the Investors of the Conversion Shares. The proceeds of this offering of Securities were used to purchase the Company’s membership interests in GMDOC.

 

The May 2022 Notes bear interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time (subject to the occurrence of an event of default) in an amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest, and shall be mandatorily repaid in cash in an amount equal to a) fifty percent (50%) of the then outstanding principal amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 but not greater than $3,000,000; or b) one hundred percent (100%) of the then outstanding principal amount equal to 120% of the principal amount of a May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of in excess of $3,000,000. In addition, pursuant to the May 2022 Notes, so long as such May 2022 Notes remain outstanding, the Company shall not enter into any financing transactions pursuant to which the Company sells its securities at a price lower than the $0.40 per share conversion price, subject to certain adjustments, without the written consent of the investors.

 

22
 

 

The conversion of the May 2022 Notes are each subject to beneficial ownership limitations such that the investors may not convert the May 2022 Notes to the extent that such conversion or exercise would result in an investor being the beneficial owner in excess of 4.99% (or, upon election of the Investor, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

Pursuant to the purchase agreement for the Securities, for a period of twelve (12) months after the closing date, the investors have a right to participate in any issuance of the Company’s Common Stock, Common Stock equivalents, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of the subsequent financing.

 

The Company also entered into that certain registration rights side letter, pursuant to which, in the event the Company’s shares of Common Stock have not commenced trading on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date, and, thereafter, the Company agreed to file a registration statement under the Securities Act to register the offer and sale, by the Company, of Common Stock underlying the May 2022 Notes in the event that such notes are not repaid prior to such 120-day period.

 

The Company paid half of the May 2022 Notes principal balance upon its maturity on June 29, 2022 and an additional $112,500 in September 2022 and the remaining balance remains due and payable and was therefore in technical default as of December 31, 2022.

 

The Company and the two May 2022 Note Holders reached an agreement on January 10, 2023. On January 10, 2023, the Company amended each of those notes by entering into a Letter Agreement between the investors and the Company. The Letter Agreement modifies the terms of the May 2022 Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes.

 

The Company evaluated the terms of the January 10, 2023 Letter Agreement which amended the May 2022 Notes. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the May 2022 Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The amendment of the Fixed Conversion Price to $0.10 from $0.50 per share, as provided for in the Letter Agreement, would be considered substantive based on the likelihood of the conversion option being exercised in the future. Accordingly, the Company accounted for the amendment of the Notes as an extinguishment of the original Bridge Notes.

 

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment:

 

  

As of

January 10, 2023

 
Carrying value of the original convertible notes payable     
Principal balance  $312,500 
Accrued interest   75,471 
Total carrying value of original convertible note payable   387,971 
      
Less: Net present value of future cash flows on amended convertible notes payable   (322,986)
      
Gain on extinguishment of convertible notes payable  $64,985 

 

23
 

 

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment exceeded 10%. As a result, the Company recorded a gain on extinguishment of convertible notes payable totaling $64,985 during the three months ended March 31, 2023.

 

On January 13, 2023, one of the May 22 Note holders exercised its right to convert $46,296 of principal and $3,704 accrued interest into 500,000 shares of common stock. The remaining outstanding principal balance on the two May 2022 Notes totaled $266,204 and $312,500 as of March 31, 2023 and December 31, 2022, respectively.

 

Note 5 – Accrued liabilities

 

Accrued liabilities consisted of the following at March 31, 2023 and December 31, 2022:

 

         
   March 31, 2023   December 31, 2022 
Accrued rent  $614,918   $614,918 
Accrued Nicaragua Concession fees   544,485    544,485 
           
Total accrued liabilities  $1,159,403   $1,159,403 

 

The accrued rent balances relate to unpaid rent for the Company’s previous headquarters in Denver, Colorado and represents unpaid rents and related costs for the period June 2006 through November 2008. The Company has not had any correspondence with the landlord for several years and will seek to settle and/or negotiate the matter when it has the financial resources to do so.

 

From 2009 to 2020, the Company had pursued the exploration of potential oil and gas resources in the United States and in the Perlas and Tyra concession blocks in offshore Nicaragua in the Caribbean Sea (the “Concessions”), which contain a total of approximately 1.4 million acres. In January 2020, the Company decided to cease its activities, exploration and production in the Concessions. The accrued Nicaraguan Concession fees were accrued during the time the Concessions had lapsed and the Company was attempting to negotiate extensions to the underlying concessions with the Nicaraguan government which were unsuccessful. The Company abandoned all efforts to negotiate an extension to the Concessions effective January 1, 2020 and ceased the accrual of all related fees at that time.

 

Note 6 – Stock Options

 

Total stock-based compensation is comprised of the following for the three months ended March 31, 2023 and 2022:

 

   Three Months ended
March 31,
 
   2023   2022 
Stock-based compensation – stock option grants  $   $76,500 
           
Stock-based compensation – restricted stock grants   174,375    81,250 
           
Stock-based compensation – warrants issued for services pursuant to USNG Letter Agreement (defined below)   71,716    72,156 
           
Total stock-based compensation  $246,091   $229,906 

 

24
 

 

The Company applies ASC 718, Stock Compensation, which requires companies to recognize compensation expense for share-based payments based on the estimated fair value of the awards. ASC 718 also requires tax benefits relating to the deductibility of increases in the value of equity instruments issued under share-based compensation arrangements to be presented as financing cash inflows in the statement of cash flows. Compensation cost is recognized based on the grant-date fair value for all share-based payments granted and is estimated in accordance with the provisions of ASC 718.

 

At the Company’s Annual Meeting of Stockholders held on September 25, 2015, the stockholders approved the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”) and the Company reserved 500,000 shares for issuance under the 2015 Plan. At the Company’s Annual Meeting of Stockholders held on October 13, 2021, the stockholders approved the 2021 Stock Option and Restricted Stock Plan (the “2021 Plan”) and the Company reserved 5,000,000 shares for issuance under the 2021 Plan.

 

The 2021 Plan and the 2015 Plan provide for under which both incentive and non-statutory stock options may be granted to employees, officers, non-employee directors and consultants. An aggregate of 5,500,000 shares of the Company’s Common Stock is reserved for issuance under the 2021 Plan and the 2015 Plan. Options granted under the 2021 Plan and 2015 Plan allow for the purchase of shares of Common Stock at prices not less than the fair market value of such stock at the date of grant, become exercisable immediately or as directed by the Company’s Board of Directors and generally expire ten years after the date of grant. The Company has issued stock options and restricted stock awards that are not pursuant to a formal plan with terms similar to the 2021 and 2015 Plans.

 

As of March 31, 2023, 5,500,000 shares were available for future grants under the 2021 Plan and the 2015 Plan.

 

The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the expected term of the option award, expected stock price volatility and expected dividends. These estimates involve inherent uncertainties and the application of management judgment. For purposes of estimating the expected term of options granted, the Company aggregates option recipients into groups that have similar option exercise behavioral traits. Expected volatilities used in the valuation model are based on the expected volatility based on historical volatility. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The Company’s forfeiture rate assumption used in determining its stock-based compensation expense is estimated based on historical data. The actual forfeiture rate could differ from these estimates.

 

Stock option grants

 

The following table summarizes stock option activity for the three months ended March 31, 2023 and 2022:

 

   Number of Options  

Weighted Average Exercise

Price Per

Share

  

Weighted

Average

Remaining
Contractual
Term

  

Aggregate

Intrinsic

Value

 
Outstanding at December 31, 2021   1,892,000   $1.93    9.07 years   $ 
Granted                  
Exercised                  
Forfeited                 
Outstanding at March 31, 2022   1,892,000   $1.93    8.82 years   $ 
Outstanding and exercisable at March 31, 2022   92,000   $30.00    1.79 years   $ 
                     
Outstanding at December 31, 2022   1,442,000   $2.38    7.96 years   $ 
Granted                  
Exercised                  
Forfeited                  
Outstanding at March 31, 2023   1,442,000   $2.38    7.71 years   $ 
Outstanding and exercisable at March 31, 2023   1,442,000   $2.38    7.71 years   $ 

 

25
 

 

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of March 31, 2023:

 

    Outstanding options   Exercisable options 

Exercise price

per share

  

Number of

options

   Weighted average
remaining
contractual life
  

Number of

options

   Weighted average
remaining
contractual life
 
                       
$0.50    1,350,000    8.18 years    1,350,000    8.18 years 
$30.00    92,000    0.79 years    92,000    0.79 years 
                       
 Total    1,442,000    7.71 years    1,442,000    7.71 years 

 

There were no stock options granted during the three months ended March 31, 2023 and 2022. The Company recorded stock-based compensation expense in connection with the vesting of stock options granted aggregating $-0- and $76,500 for the three months ended March 31, 2023 and 2022, respectively.

 

The intrinsic value as of March 31, 2023 and December 31, 2022 related to the vested and unvested stock options as of that date was $-0-. There is no unrecognized compensation cost as of March 31, 2023 related to the unvested stock options as of that date.

 

Restricted stock grants.

 

During May 2022, the Board of Directors granted 1,550,000 shares of restricted stock awards to our officers, directors and consultants. In addition, during August 2020 the Board of Directors granted 5,000,000 shares of restricted stock awards to our officers, directors and a consultant. Restricted stock awards are valued on the date of grant and have no purchase price for the recipient. Restricted stock awards typically vest over a period of time generally corresponding to yearly anniversaries of the grant date. Unvested shares of restricted stock awards may be forfeited upon the termination of service of employment with the Company, depending upon the circumstances of termination. Except for restrictions placed on the transferability of restricted stock, holders of unvested restricted stock have full stockholder’s rights, including voting rights and the right to receive cash dividends.

 

A summary of all restricted stock activity under the equity compensation plans for the three months ended March 31, 2023 and 2022 is as follows:

 

  

Number of

restricted

shares

  

Weighted

average

grant date

fair value

 
Nonvested balance, December 31, 2021   1,250,000   $0.13 
Granted        
Vested   (625,000)   (0.13)
Forfeited        
Nonvested balance, March 31, 2022   625,000   $0.13 
           
Nonvested balance, December 31, 2022   387,500   $0.45 
Granted        
Vested   (387,500)   (0.45)
Forfeited        
Nonvested balance, March 31, 2023      $ 

 

26
 

 

The Company recorded stock-based compensation expense in connection with the issuance/vesting of restricted stock grants aggregating $174,375 and $81,250 during the three months ended March 31, 2023 and 2022, respectively.

 

The Company estimated the fair market value of these restricted stock grants based on the closing market price on the date of grant. As of March 31, 2023, there were $-0- of total unrecognized compensation costs related to all remaining non-vested restricted stock grants as all restricted stock granted to date have fully vested.

 

Note 7 – Warrants

 

The following table summarizes warrant activity for the three months ended March 31, 2023 and 2022:

 

  

Number of

Warrants

  

Weighted

Average

Exercise Price

Per Share

 
Outstanding and exercisable at December 31, 2021   17,580,784   $0.47 
Forfeited/expired        
Outstanding and exercisable at March 31, 2022   17,580,784   $0.47 
           
Outstanding and exercisable at December 31, 2022   20,430,783   $0.45 
Forfeited/expired        
           
Outstanding and exercisable at March 31, 2023   20,430,783   $0.45 

 

The weighted average term of all outstanding Common Stock purchase warrants was 3.5 years as of March 31, 2023. The intrinsic value of all outstanding Common Stock purchase warrants and the intrinsic value of all vested Common Stock purchase warrants was zero as of March 31, 2023 and 2022.

 

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase common shares as of March 31, 2023:

 

    Outstanding and exercisable warrants 

Exercise price

per share

  

Number of

warrants

  

Weighted average

remaining contractual life

 
$0.30    2,149,999    4.8 years 
$0.39    5,256,410    3.5 years 
$0.50    13,024,374    3.3 years 
             
 Total    20,430,783    3.5 years 

 

Warrants issued pursuant to USNG Letter Agreement

 

On November 9, 2021, the Company entered into a letter agreement (the “USNG Letter Agreement”) with U.S. Noble Gas, LLC (“USNG”), pursuant to which USNG provides consulting services to the Company for exploration, testing, refining, production, marketing and distribution of various potential reserves of noble gases and rare earth element/minerals on the Company’s recently acquired 11,000-acre oil and gas properties in the Otis Albert Field located on the Properties. The USNG Letter Agreement would cover all of the noble gases, specifically including helium, and rare earth elements/minerals potentially existing on Properties and the Company’s future acquisitions, if any, including the Hugoton Gas Field.

 

27
 

 

The USNG Letter Agreement also provides that USNG will supply a large vessel designed for flows up to 5,000 barrels of water per day at low pressures, known as a gas extraction/separator unit. The gas extraction/separator unit is a dewatering vessel that the Company may use for multiple wells in the future.

 

The USNG Letter Agreement requires the Company to establish a four-member board of advisors (the “Board of Advisors”) comprised of various experts involved in noble gas and rare earth elements/minerals. The Board of Advisors will help attract both industry partners and financial partners for developing a large helium, noble gas and/or rare earth element/mineral resources that may exist in the region where the Company currently operates. The industry partners would include helium, noble gas and/or rare earth element/mineral purchasers and exploration and development companies from the energy industry. The financial partners may include large family offices or small institutions.

 

Pursuant to the USNG Letter Agreement, the Company will pay USNG a monthly cash fee equal to $8,000 per month beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore, there has been no payment or accrual liability relative to this cash fee provision as of March 31, 2023 and December 31, 2022.

 

The USNG Letter Agreement has an initial term of 5 years, which shall thereafter continue for successive one-year periods, provided that there is no uncured breach, unless otherwise terminated by either party upon a written notice of intent to non-renew.

 

In consideration for the consulting services to be rendered and pursuant to the terms of the USNG Letter Agreement, the Company issued warrants to purchase, in the aggregate, 2,060,000 shares of its Common Stock at an exercise price of fifty cents ($0.50) to three of USNG’s principal consultants and four third-party service providers. The Company issued warrants to purchase, in the aggregate, 1,200,000 shares of Common Stock at fifty cents ($0.50) per share exercise price to three members of the Board of Advisors. The Company granted a total of 3,260,000 warrants to purchase its Common Stock with an exercise price of fifty cents ($0.50) per share in connection with the USNG Letter Agreement and the arrangements described therein. The warrants expire five years after the date of the USNG Letter Agreement.

 

The fair value of the warrants to purchase Common Stock in consideration for services to be rendered under the USNG Letter Agreement with USNG is estimated on the date of grant using the Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the expected term of the warrant, expected stock price volatility and expected dividends. These estimates involve inherent uncertainties and the application of management judgment. For purposes of estimating the expected term of warrants granted, the Company considered the historical pattern of warrant exercises behavioral traits and determined that the expected term should be 5 years. Expected volatilities used in the valuation model are based on the expected volatility based on historical volatility. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The Company’s forfeiture rate assumption used in determining its stock-based compensation expense is estimated based on historical data. The actual forfeiture rate could differ from these estimates.

 

28
 

 

The following are the assumptions used in calculating the estimated grant-date fair value of the warrants issued pursuant to the USNG Letter Agreement granted on November 9, 2021:

 

  

As of

November 9, 2021

(issuance date)

 
     
Volatility – range   359.3%
Risk-free rate   1.08%
Expected term   5.0 years 
Exercise price  $0.50 
Number of warrants in aggregate   3,260,000 

 

The Company recognized $71,716 and $72,156 of compensation expense relative to the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement during the three months ended March 31, 2023 and 2022, respectively. There have been no exercises or forfeitures of the warrants to purchase Common Stock relative to the USNG Letter during the three months ended March 31, 2023 and 2022.

 

The total grant date fair value of the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement on November 9, 2021 was $1,434,313 in total or $0.44 per share. Total unrecognized compensation costs related to the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement, as of March 31, 2023 was $1,027,923 which will be amortized over the next forty-three months.

 

Note 8 – Income Taxes

 

The effective income tax rate on income (loss) before income tax benefit varies from the statutory federal income tax rate primarily due to the net operating loss history of the Company maintaining a full reserve on all net deferred tax assets during the three months ended March 31, 2023 and 2022.

 

The Company has incurred operating losses in recent years, and it continues to be in a three-year cumulative loss position at March 31, 2023. Accordingly, the Company determined there was not sufficient positive evidence regarding its potential for future profits to outweigh the negative evidence of our three-year cumulative loss position under the guidance provided in ASC 740. Therefore, it determined to continue to provide a 100% valuation allowance on its net deferred tax assets. The Company expects to continue to maintain a full valuation allowance until it determines that it can sustain a level of profitability that demonstrates its ability to realize these assets. To the extent the Company determines that the realization of some or all of these benefits is more likely than not based upon expected future taxable income, a portion or all of the valuation allowance will be reversed.

 

For income tax purposes, the Company has net operating loss carry-forwards of approximately $64,710,000 in accordance with its 2021 Federal Income tax return as filed. Approximately $61,045,000 of such net operating loss carry-forwards expire from 2028 through 2037 while $1,935,000 of such net operating loss carry-forwards have an indefinite carryforward period in accordance with the Tax Cuts and Jobs Act. In addition, the Tax Cuts and Jobs Act limits the usage of net operating loss carryforwards to 80% of taxable income per year.

 

The Company has recently completed the filing of its tax returns for the tax years 2012 through 2021. Therefore, all such tax returns are open to examination by the Internal Revenue Service.

 

The Internal Revenue Code contains provisions under Section 382 which limit a company’s ability to utilize net operating loss carry-forwards in the event that it has experienced a more than 50% change in ownership over a three-year period. Management has completed its review of whether such ownership changes have occurred, and based upon such review, management believes that the Company is not currently subject to an annual limitation or the possibility of the complete elimination of the net operating loss carry- forwards. In addition, the Company may be limited by additional ownership changes which may occur in the future.

 

29
 

 

Note 9 – Gain on Extinguishment of Convertible Notes Payable

 

During the three months ended March 31, 2023 and 2022, the Company recorded gains on the extinguishment of convertible notes payable through negotiation and settlements with certain creditors as follows:

 

         
  

Three months ended

March 31,

 
   2023   2022 
Gain on extinguishment of convertible notes payable:          
Gain on extinguishment of convertible notes payable –
the October 8% Notes (See Note 4)
  $103,977   $ 
Gain on extinguishment of convertible notes payable –
the May 22 Notes (see Note 4)
   64,985     
           
Total gain on extinguishment of convertible notes payable  $168,962   $ 

 

Note 10 – Asset Retirement Obligations

 

The Company’s asset retirement obligations primarily relate to the Company’s portion of future plugging and abandonment costs for wells and related facilities. The following table presents the changes in the asset retirement obligations for the three months ended March 31, 2023 and 2022:

 

   Amount 
     
Asset retirement obligation at December 31, 2021  $1,730,264 
Additions    
Accretion expense during the period   279 
      
Asset retirement obligation at March 31, 2022  $1,730,543 
      
Asset retirement obligation at December 31, 2022  $1,732,486 
Additions    
Accretion expense during the period   1,218 
      
Asset retirement obligation at March 31, 2023  $1,733,704 

 

Approximately $1,716,003 of the total asset retirement obligation existing at March 31, 2023 and December 31, 2022 represent the remaining potential liability for oil and gas wells the Company had owned in Texas and Wyoming prior to their sales/disposal in 2012. The Company was not in compliance with then existing federal, state and local laws, rules and regulations for its previously owned Texas and Wyoming domestic oil and gas properties. All domestic oil and gas properties held by Infinity-Wyoming and Infinity-Texas were disposed of in 2012 and in years prior to 2012; however, the Company may remain liable for certain asset retirement costs should the new owners not complete their asset retirement obligations. Management believes the total asset retirement obligations recorded relative to all the Company wells including these Texas and Wyoming wells of $1,733,704 and $1,732,486 as of March 31, 2023 and December 31, 2022, respectively are sufficient to cover any potential noncompliance liabilities relative to the plugging of abandoned wells, the removal of facilities and equipment, and site restoration on oil and gas properties for its current and former oil and gas properties.

 

Note 11 – Warrant Derivative Liability

 

The estimated fair value of the Company’s derivative liabilities, all of which were related to the detachable warrants issued in connection with Series A Convertible Preferred Stock, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates. The detachable warrants issued in connection with the issuance of certain Series A Convertible Preferred Stock (See Note 13 - March 2021 Issuance) contained a provision allowing the holder to require cash settlement in certain situations were fundamental transaction, as defined in the warrant agreements have occurred. An event occurred on December 31, 2022 that activated the Holder’s ability to utilize such provisions therefore the related derivative liability was recognized on December 31, 2022 and also at March 31, 2023.

 

30
 

 

The following is a summary of the assumptions used in calculating estimated fair value of such derivative liabilities as of the March 31, 2023 and December 31, 2022:

 

  

As of

March 31, 2023

  

As of

December 31, 2022

 
         
Volatility – range   347.7%   342.2%
Risk-free rate   3.58%   3.99%
Contractual term   3.49 years    3.74 years 
Exercise price  $0.39   $0.39 
Number of warrants in aggregate   5,256,410    5,256,410 

 

The following table provides a summary of the changes in fair value, including net transfers in and/or out, of the derivative financial instruments, measured at fair value on a recurring basis using significant unobservable inputs for both open and closed derivatives:

   Amount 
Balance at December 31, 2021  $ 
Unrealized derivative gains included in other income/expense for the period    
Balance at March 31, 2022  $ 
Balance at December 31, 2022  $577,269 
Unrealized derivative gains included in other income/expense for the period   (367,467)
      
Balance at March 31, 2023  $209,802 

 

Note 12 – Commitments and Contingencies

 

Lack of Compliance with Law Regarding Domestic Properties

 

The Company was not in compliance with then existing federal, state and local laws, rules and regulations for domestic oil and gas properties owned and disposed of in 2012 and in years prior to 2012 and could have a material or significantly adverse effect upon the liquidity, capital expenditures, earnings or competitive position of the Company. All domestic oil and gas properties held by Infinity-Wyoming and Infinity-Texas were disposed of in 2012 and in years prior to 2012; however, the Company may remain liable for certain asset retirement costs should the new owners not complete their obligations. Management believes the total asset retirement obligations recorded for these prior matters of $1,716,003 as of March 31, 2023 and December 31, 2022 are sufficient to cover any potential noncompliance liabilities relative to the plugging of abandoned wells, the removal of facilities and equipment, and site restoration on oil and gas properties for its former oil and gas properties.

 

USNG Letter Agreement commitment

 

Pursuant to the USNG Letter Agreement (see Note 7), the Company will pay USNG a monthly cash fee equal to $8,000 per month beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore there has been no payment or accrual liability relative to this cash fee provision as of March 31, 2023 and December 31, 2022.

 

31
 

 

The USNG Letter Agreement has an initial term of 5 years, which shall thereafter continue for successive one-year periods, provided that there is no uncured breach, unless otherwise terminated by either party upon a written notice of intent to non-renew.

 

Litigation

 

The Company is subject to various claims and legal actions in which vendors are claiming breach of contract due to the Company’s failure to pay amounts due. The Company believes that it has made adequate provision for these claims in the accompanying financial statements.

 

The Company is currently involved in litigation as follows:

 

In October 2012, the State of Texas filed a lawsuit naming Infinity-Texas, the Company and the corporate officers of Infinity-Texas, seeking $30,000 of reclamation costs associated with a single well, in addition to administrative expenses and penalties. The Company engaged in negotiations with the State of Texas in late 2012 and early 2013 and reached a settlement agreement that would reduce the aggregate liability, in this action and any extension of this action to other Texas wells, to $45,103, which amount has been paid. Certain performance obligations remain which must be satisfied in order to finally settle and dismiss the matter.
   
  Pending satisfactory performance of the performance obligations and their acceptance by the State of Texas, the Company’s officers have potential liability regarding the above matter, and the Company’s officers are held personally harmless by indemnification provisions of the Company. Therefore, to the extent they might actually occur, these liabilities are the obligations of the Company. Management estimates that the liabilities associated with this matter will not exceed $780,000, calculated as $30,000 for each of the 26 Infinity-Texas operated wells. This related liability, less the payment made to the State of Texas in 2012 in the amount of $45,103, is included in the asset retirement obligation on the accompanying balance sheets, which management believes is sufficient to provide for the ultimate resolution of this dispute.

 

Cambrian Consultants America, Inc. (“Cambrian”) filed an action in the District Court of Harris County, Texas, number CV2014-55719, on September 26, 2014 against the Company resulting from certain professional consulting services provided for quality control and management of seismic operations during November and December 2013 on the Nicaraguan Concessions. Cambrian provided these services pursuant to a Master Consulting Agreement with the Company, dated November 20, 2013, and has claimed breach of contract for failure to pay amounts due. On December 8, 2014, a default judgment was entered against the Company in the amount of $96,877 plus interest and attorney fees. The Company has included the impact of this litigation as a liability in its accounts payable, which management believes is sufficient to provide for the ultimate resolution of this dispute.
   
Torrey Hills Capital, Inc. (“Torrey”) notified the Company by letter, dated August 15, 2014, of its demand for the payment of $56,000, which it alleged was unpaid and owed under a consulting agreement dated October 18, 2013. The parties entered into a consulting agreement under which Torrey agreed to provide investor relations services in exchange for payment of $7,000 per month and the issuance of 15,000 shares of Common Stock. The agreement was for an initial three month-term with automatic renewals unless terminated upon 30 days’ written notice by either party. The Company made payments totaling $14,000 and issued 15,000 shares of Common Stock during 2013. The Company contends that Torrey breached the agreement by not performing the required services and that it had provided proper notice of termination to Torrey. Furthermore, the Company contends that the parties agreed to settle the dispute on or about June 19, 2014 under which it would issue 2,800 shares of Common Stock in full settlement of any balance then owed and final termination of the agreement. Torrey disputed the Company’s contentions and submitted the dispute to binding arbitration. The Company was unable to defend itself and the arbitration panel awarded Torrey a total of $79,594 in damages. The Company has accrued this amount in accounts payable as of March 31, 2023 and December 31, 2022, which management believes is sufficient to provide for the ultimate resolution of this dispute.

 

32
 

 

Note 13 – Stockholder’s Deficit

 

Conversion of 8% Convertible Notes Payable to Common Stock.

 

On January 13, 2023, a holder of 8% Convertible Notes Payable exercised its right to convert $46,296 of principal and $3,704 of accrued interest into 500,000 shares of common stock.

 

Series A Convertible Preferred Stock

 

As of March 31, 2023 and December 31, 2022, the Company is authorized to issue up to 10,000,000 shares of preferred stock, par value $0.0001 per share.

 

The following summarizes the activity in Series A Convertible Preferred Stock for the three months ended March 31, 2023 and 2022:

 

  

Number of

Shares

 
Outstanding at December 31, 2021   22,076 
Issued    
Converted to Common Stock   (800)
      
Outstanding at March 31, 2022   21,276 
      
Outstanding at December 31, 2022   25,526 
Issued    
Converted to Common Stock    
      
Outstanding at March 31, 2023   25,526 

 

On March 16, 2021, the Company approved and filed a Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock (“COD”) with the Secretary of State of the State of Delaware. The COD provides for the issuance of up to 27,778 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share. Pursuant to the provisions of the COD, the Series A Convertible Preferred Stock is convertible, at the option of the holders thereof, at any time, subject to certain beneficial ownership limitations, into shares of Common Stock determined on a per share basis by dividing the $100 stated/liquidation value of such share of Series A Convertible Preferred Stock by the $0.32 per share conversion price, which conversion price is subject to certain adjustments. In addition, the COD provides for the payment of 10% per annum cumulative dividends, in (i) cash, or (ii) shares of Common Stock, to the holders of the Series A Convertible Preferred Stock based on the stated/liquidation value, until the earlier of (i) the date on which the shares of Series A Convertible Preferred Stock are converted to Common Stock or (ii) date the Company’s obligations under the COD have been satisfied in full. The shares of Series A Convertible Preferred Stock also (i) vote on an as-converted to Common Stock basis, subject to certain beneficial ownership limitations, (ii) are subject to mandatory conversion into Common Stock upon the closing of any equity financing transaction consummated after the original issue date, pursuant to which the Company raises gross proceeds of not less than $5,000,000, (iii) rank senior to the Common Stock and any class or series of capital stock created after the Series A Convertible Preferred Stock and (iv) have a special preference upon the liquidation of the Company.

 

March 2021 Issuance - On March 26, 2021, the Company entered into a securities purchase agreement with five (5) accredited investors providing for an aggregate investment of $2,050,000 by the investors for the issuance by the Company to them of (i) 22,776 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “March 2021 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 5,256,410 shares of Common Stock at an exercise price of thirty-nine ($0.39) per share, subject to customary adjustments thereunder. The March 2021 Series A Convertible Preferred Stock is convertible into an aggregate of up to 7,117,500 shares of Common Stock. Holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrants. Net proceeds from the issuance of March 2021 Series A Convertible Preferred Stock totaled $1,929,089 after deducting the placement agent fee and other expenses of the offering. The Company used the proceeds of the March 2021 Series A Convertible Preferred Stock offering to complete the acquisition and development of the Properties, to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

 

33
 

 

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the acquisition of the Properties, which occurred on April 1, 2021, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90th) calendar day following the closing of the acquisition of the Properties, which occurred on April 1, 2021. The Company completed the required registration of these shares on Form S-1, which the Securities and Exchange Commission declared effective on August 4, 2021.

 

The holders of the March 2021 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its March 2021 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

 

The Company has accrued preferred dividends totaling $47,037 and $52,861 relative to the March 2021 Series A Convertible Preferred Stock which was charged to additional paid in capital during the three months ended March 31, 2023 and 2022, respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $91,842 and $44,805 relative to the March 2021 Series A Convertible Preferred Stock as of March 31, 2023 and December 31, 2022, respectively.

 

The holders of March 2021 Series A Convertible Preferred Stock did not exercise their rights to convert any of the March 2021 Series A Convertible Preferred Stock into shares of Common Stock during the three months ended March 31, 2023. The holders exercised their rights to convert a total of 800 shares of March 2021 Series A Convertible Preferred Stock into 250,000 shares of Common Stock during the three months ended March 31, 2022.

 

On March 26, 2021, Ozark Capital, LLC (“Ozark”) acquired 1,111 shares of March 2021 Series A Convertible Preferred Stock (convertible into 347,188 shares of Common Stock), together with warrants to acquire 256,410 shares of Common Stock at fifty cents ($0.50) per share for a total cash of $100,000. Ozark and its affiliates hold over 10% of the shares of the Company’s Common Stock as of March 31, 2023 and December 31, 2022. Accrued dividends attributable to Ozark were $2,739 and $2,740 for the three months ended March 31, 2023 and 2022 respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $5,540 and $2,800 relative to the Ozark’s Series A Convertible Preferred Stock as of March 31, 2023 and December 31, 2022, respectively.

 

All holders of the March 2021 Series A Convertible Preferred Stock, including Ozark, have agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days’ advance notice to the Company.

 

June 2022 Issuance - On June 15, 2022, the Company entered into a securities purchase agreement with an accredited investor providing for an aggregate investment of $500,000 by the investor for the issuance by the Company of (i) 5,000 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “June 2022 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 1,666,667 shares of Common Stock at an exercise price of thirty cents ($0.30) per share, subject to customary adjustments thereunder. The June 2022 Series A Convertible Preferred Stock is convertible into an aggregate of up to 1,562,500 shares of Common Stock. The holder of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of the June 2022 Series A Convertible Preferred Stock totaled $500,000. The Company used the proceeds of the June 2022 Series A Convertible Preferred Stock offering to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

 

34
 

 

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the of the June 2022 Series A Preferred Stock, which occurred on June 15, 2022, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90th) calendar day following the closing of the offering, which occurred on June 15, 2022.

 

The holder of the June 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its June 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

 

The Company has accrued preferred dividends totaling $12,329 and $-0- relative to the June 2022 Series A Convertible Preferred Stock which was charged to additional paid in capital during the three months ended March 31, 2023 and 2022, respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $39,589 and $27,260 relative to the June 2022 Series A Convertible Preferred Stock as of March 31, 2023 and December 31, 2022, respectively.

 

August/September 2022 Issuances – During August and September 2022, the Company entered into a securities purchase agreement with three accredited investors providing for an aggregate investment of $145,000 by the investors for the issuance by the Company of (i) 1,450 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “August/September 2022 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 483,332 shares of Common Stock at an exercise price of thirty ($0.30) per share, subject to customary adjustments thereunder. The August/September 2022 Series A Convertible Preferred Stock is convertible into an aggregate of up to 453,125 shares of Common Stock. The holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of the August/September 2022 Series A Convertible Preferred Stock totaled $145,000. The Company used the proceeds of the August/September 2022 Series A Convertible Preferred Stock offering to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

 

The holders of the August/September 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its August/September 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

 

The Company has accrued preferred dividends totaling $3,575 and $-0- relative to the August/September 2022 Series A Convertible Preferred Stock which was charged to additional paid in capital during the three months ended March 31, 2023 and 2022, respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $8,634 and $5,059 relative to the August/September 2022 Series A Convertible Preferred Stock as of March 31, 2023 and December 31, 2022, respectively.

 

Note 14 – Related Party Transactions

 

The Company does not have any employees other than its Chief Executive Officer, Chief Operating Officer and Chief Financial Officer. In previous years, certain general and administrative services (for which payment is deferred) had been provided by the Company’s Chief Financial Officer’s accounting firm at its standard billing rates plus out-of-pocket expenses consisting primarily of accounting, tax and other administrative fees. The Company no longer utilizes its Chief Financial Officer’s accounting firm for such support services and was not billed for any such services during the years ended December 31, 2022 and 2021. On March 31, 2021, the parties entered into a Debt Settlement Agreement whereby all amounts due to such firm for services totaling $762,407 were extinguished upon the issuance of $7,624 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in Note 4. Total amounts due to the related party was $-0- as of March 31, 2023 and December 31, 2022.

 

35
 

 

The Company had accrued compensation to its officers and directors in years prior to 2018. The Board of Directors authorized the Company to cease the accrual of compensation for its officers and directors, effective January 1, 2018. On March 31, 2021, the parties entered into Debt Settlement Agreements whereby all accrued amounts due for such services totaling $1,789,208 were extinguished upon the issuance of $17,892 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in Note 4. Total amounts due to the officers and directors related to accrued compensation was $-0- as of March 31, 2023 and December 31, 2022.

 

Offshore Finance, LLC was owed financing costs in connection with a subordinated loan to the Company which was converted to common shares in 2014. The managing partner of Offshore and the Company’s Chief Financial Officer are partners in the accounting firm which the Company used for general corporate purposes in the past. On March 31, 2021, the parties entered into a Debt Settlement Agreement whereby all amounts due for such services totaling $26,113 were extinguished upon the issuance of $